← H B Fuller overview

H B Fuller vs Shin-Etsu Chemical Co.: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

H B Fuller Company (FUL)

Q3 2026
▲2

Fuller's profit beat and buyout battle reshape its path

  • Strong Q2 earnings and raised guidance Fuller's second-quarter profit rose 19% to $1.41 per share, revenue grew 5.8%, and the company raised its full-year profit outlook. This shows the core business is performing well, which supports a higher stock price.

    This is the main positive fundamental driver for FUL's price this period.

  • Acquisition of Advanced Medical Solutions Fuller agreed to buy Advanced Medical Solutions for £715 million, moving into higher-growth medical adhesives. The deal should boost long-term growth but will temporarily raise debt to about 4 times earnings, and an activist investor opposes it.

    This is a major strategic move that affects FUL's growth and risk profile.

  • Ancora's buyout offer for building adhesives unit Ancora offered $1.1–1.2 billion for Fuller's Building Adhesives Solutions unit, but the board rejected it as too low. The offer highlights the unit's value and could pressure management to unlock it, potentially lifting the stock.

    This event shows external interest in Fuller's assets and could lead to value creation.

July 2026
▲2

Fuller's profit beat and buyout battle reshape its path

  • Strong Q2 earnings and raised guidance Fuller's second-quarter profit rose 19% to $1.41 per share, revenue grew 5.8%, and the company raised its full-year profit outlook. This shows the core business is performing well, which supports a higher stock price.

    This is the main positive fundamental driver for FUL's price this period.

  • Acquisition of Advanced Medical Solutions Fuller agreed to buy Advanced Medical Solutions for £715 million, moving into higher-growth medical adhesives. The deal should boost long-term growth but will temporarily raise debt to about 4 times earnings, and an activist investor opposes it.

    This is a major strategic move that affects FUL's growth and risk profile.

  • Ancora's buyout offer for building adhesives unit Ancora offered $1.1–1.2 billion for Fuller's Building Adhesives Solutions unit, but the board rejected it as too low. The offer highlights the unit's value and could pressure management to unlock it, potentially lifting the stock.

    This event shows external interest in Fuller's assets and could lead to value creation.

Latest
▲2

Fuller's profit beat and buyout battle reshape its path

  • Strong Q2 earnings and raised guidance Fuller's second-quarter profit rose 19% to $1.41 per share, revenue grew 5.8%, and the company raised its full-year profit outlook. This shows the core business is performing well, which supports a higher stock price.

    This is the main positive fundamental driver for FUL's price this period.

  • Acquisition of Advanced Medical Solutions Fuller agreed to buy Advanced Medical Solutions for £715 million, moving into higher-growth medical adhesives. The deal should boost long-term growth but will temporarily raise debt to about 4 times earnings, and an activist investor opposes it.

    This is a major strategic move that affects FUL's growth and risk profile.

  • Ancora's buyout offer for building adhesives unit Ancora offered $1.1–1.2 billion for Fuller's Building Adhesives Solutions unit, but the board rejected it as too low. The offer highlights the unit's value and could pressure management to unlock it, potentially lifting the stock.

    This event shows external interest in Fuller's assets and could lead to value creation.

Shin-Etsu Chemical Co., Ltd. (4063.JP)

Q3 2026
▲2▼2

Shin-Etsu: AI demand and photoresist price hikes offset profit miss and China trade hit

  • NVIDIA deepens ties with Japanese suppliers, boosting wafer demand NVIDIA's CEO met with Shin-Etsu and other Japanese suppliers, signaling that AI expansion will keep driving demand for Shin-Etsu's silicon wafers. More AI chips mean more wafer sales, which supports future revenue and profits.

    This is a new demand signal that directly supports Shin-Etsu's core semiconductor materials business.

  • Full-year profit forecast misses market expectations, shares drop 8% Shin-Etsu projected net profit of 525 billion yen, below the 566.8 billion yen analysts expected. The weak outlook, partly from poor vinyl chloride conditions, caused the stock to fall over 8% as investors lowered their expectations.

    This is a new negative event that directly hit the stock price and reflects a real earnings shortfall.

  • Photoresist price hikes of up to 38% lift margins Shin-Etsu and peers are raising photoresist prices by 15% overall from October 1, with high-end grades up to 38% for spot orders. Higher prices should boost Shin-Etsu's revenue and profit margins in this key product line.

    This is a new pricing action that directly improves profitability for a major Shin-Etsu product.

  • China imposes up to 99.2% anti-dumping deposits on Shin-Etsu's dichlorosilane China will require deposits of up to 99.2% on imports of Shin-Etsu's dichlorosilane, a semiconductor material, starting September 8. This trade measure, seen as pressure on Japan, could hurt Shin-Etsu's sales to China and add uncertainty.

    This is a new regulatory/trade action that directly threatens Shin-Etsu's exports and adds a real counterweight.

August 2026
▲2▼2

Shin-Etsu: AI demand and photoresist price hikes offset profit miss and China trade hit

  • NVIDIA deepens ties with Japanese suppliers, boosting wafer demand NVIDIA's CEO met with Shin-Etsu and other Japanese suppliers, signaling that AI expansion will keep driving demand for Shin-Etsu's silicon wafers. More AI chips mean more wafer sales, which supports future revenue and profits.

    This is a new demand signal that directly supports Shin-Etsu's core semiconductor materials business.

  • Full-year profit forecast misses market expectations, shares drop 8% Shin-Etsu projected net profit of 525 billion yen, below the 566.8 billion yen analysts expected. The weak outlook, partly from poor vinyl chloride conditions, caused the stock to fall over 8% as investors lowered their expectations.

    This is a new negative event that directly hit the stock price and reflects a real earnings shortfall.

  • Photoresist price hikes of up to 38% lift margins Shin-Etsu and peers are raising photoresist prices by 15% overall from October 1, with high-end grades up to 38% for spot orders. Higher prices should boost Shin-Etsu's revenue and profit margins in this key product line.

    This is a new pricing action that directly improves profitability for a major Shin-Etsu product.

  • China imposes up to 99.2% anti-dumping deposits on Shin-Etsu's dichlorosilane China will require deposits of up to 99.2% on imports of Shin-Etsu's dichlorosilane, a semiconductor material, starting September 8. This trade measure, seen as pressure on Japan, could hurt Shin-Etsu's sales to China and add uncertainty.

    This is a new regulatory/trade action that directly threatens Shin-Etsu's exports and adds a real counterweight.

Latest
▲2▼2

Shin-Etsu: AI demand and photoresist price hikes offset profit miss and China trade hit

  • NVIDIA deepens ties with Japanese suppliers, boosting wafer demand NVIDIA's CEO met with Shin-Etsu and other Japanese suppliers, signaling that AI expansion will keep driving demand for Shin-Etsu's silicon wafers. More AI chips mean more wafer sales, which supports future revenue and profits.

    This is a new demand signal that directly supports Shin-Etsu's core semiconductor materials business.

  • Full-year profit forecast misses market expectations, shares drop 8% Shin-Etsu projected net profit of 525 billion yen, below the 566.8 billion yen analysts expected. The weak outlook, partly from poor vinyl chloride conditions, caused the stock to fall over 8% as investors lowered their expectations.

    This is a new negative event that directly hit the stock price and reflects a real earnings shortfall.

  • Photoresist price hikes of up to 38% lift margins Shin-Etsu and peers are raising photoresist prices by 15% overall from October 1, with high-end grades up to 38% for spot orders. Higher prices should boost Shin-Etsu's revenue and profit margins in this key product line.

    This is a new pricing action that directly improves profitability for a major Shin-Etsu product.

  • China imposes up to 99.2% anti-dumping deposits on Shin-Etsu's dichlorosilane China will require deposits of up to 99.2% on imports of Shin-Etsu's dichlorosilane, a semiconductor material, starting September 8. This trade measure, seen as pressure on Japan, could hurt Shin-Etsu's sales to China and add uncertainty.

    This is a new regulatory/trade action that directly threatens Shin-Etsu's exports and adds a real counterweight.

© 2026 MarketIVWhy